House OKs Expanded Study of Drug DES
Associated Press
WASHINGTON —
The House voted Monday to expand research and public education efforts about the dangers of DES, a drug once prescribed to pregnant mothers and now blamed for cancer in their children. The action, which was without opposition, sends the bill to the Senate.
DES, which stands for diethylstilbesterol, is a synthetic estrogen that was prescribed to some five million women from the 1940s to 1971, when it was banned. The drug was administered to reduce the risk of miscarriage.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
